Latest filing published 10 Jan 2019 for TETRAPHASE PHARMACEUTICALS INC, €10k.
Filing timeline
BuySaleInsider track record
Jacques Dumas: trading record in brief
Jacques Dumas is a declared insider of Tetraphase Pharmaceuticals Inc, with filings sourced from SEC (Form 4). We count 9 filings; the first trade dates from 17 August 2017 and the latest from 8 January 2019.
The open-market record consists of 6 sales worth €262k, with no purchase. Besides market trades, the filings include 3 option exercises. Since January 2019: no purchases and 1 sale on the market.
The record was last updated on 10 January 2019 with an open-market sale (€10k) in Tetraphase Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jacques Dumas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,497 shares@ US$1.608.9% of flowCommon StockSEC:0001209191-19-003290:0
- 8,750 shares@ US$3.697.0% of flowCommon StockSEC:0001209191-18-006210:0
- 8,750 shares@ US$6.2211.9% of flowCommon StockSEC:0001209191-18-006210:1
- 7,167 shares@ US$6.2110.0% of flowCommon StockSEC:0001209191-18-003253:0
- 8,750 shares@ US$3.697.5% of flowCommon StockSEC:0001209191-17-058940:0
- 8,750 shares@ US$6.0312.2% of flowCommon StockSEC:0001209191-17-058940:1
- 17,500 shares@ US$3.6914.8% of flowCommon StockSEC:0001209191-17-050140:0
- 17,500 shares@ US$6.0024.1% of flowCommon StockSEC:0001209191-17-050140:1
- 7,155 shares@ US$5.869.7% of flowCommon StockSEC:0001209191-17-049702:0
9 of 9 declarations